Long term results of our regimen in EGFR mutation positive NSCLC. The combination is active Vanita Noronha, MBBS MD DM Nandini Menon Dr Amol Akhade Lung Connect India Sewanti Limaye 🇮🇳🇺🇸 Navneet Singh Prabhat Malik jamanetwork.com/journals/jamao…
New in Translational #CancerBiology from the April 15 issue:
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant #LungCancer in Permissive Cellular Contexts, by Bomiao Hu, Dr. Katerina Politi et al.
bit.ly/3WltzzP
Yale Pathology Yale Cancer Center
🎉Thrilled to share our research trustee Gini Harrison has been made Prof of Psychology. Gini is a key member of the #EGFR + community & since her diagnosis has dedicated her efforts to supporting research advances & enhancing support for those with #LungCancer . Congrats Gini! 💜
Captivating finding of cast within a cast , waxy cast within dense granular cast
eGFR 22 ml/min
Proteinuria (100 mg/dl)
Jay R. Seltzer Juan Carlos Q Velez
#urinarysediment
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in NSCLC onlinelibrary.wiley.com/doi/10.1111/ca…
✅In the 20/330pts w/ initially 'un'detected EGFR, ALK, ROS1, and BRAF V600E before CGP, these driver oncogenes were newly detected(EGFR ex20ins in 12pts)